Page last updated: 2024-09-05

magnolin and epidermal growth factor

magnolin has been researched along with epidermal growth factor in 2 studies

Compound Research Comparison

Studies (magnolin)	Trials (magnolin)	Recent Studies (post-2010) (magnolin)	Studies (epidermal growth factor)	Trials (epidermal growth factor)	Recent Studies (post-2010) (epidermal growth factor)
27	0	19	24,155	217	4,699

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, YY; Choi, KI; Jang, JH; Lee, CJ; Lee, HS; Lee, MH; Oh, SR; Ryu, HW; Song, JH; Surh, YJ; Yoo, SM	1
An, HJ; Cho, YY; Kang, HC; Kim, DJ; Kim, KD; Lee, CJ; Lee, HS; Lee, JY; Yoo, SM	1

Other Studies

2 other study(ies) available for magnolin and epidermal growth factor

Article	Year
Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway. BMC cancer, 2015, Aug-08, Volume: 15 Topics: Animals; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; Mice; NF-kappa B; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Transcriptional Activation	2015
Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells. Molecular carcinogenesis, 2019, Volume: 58, Issue:7 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chemoprevention; Drugs, Chinese Herbal; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3 beta; HEK293 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Lignans; Lung Neoplasms; Mice; Molecular Docking Simulation; Phosphorylation; Protein Conformation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Ribosomal Protein S6 Kinases, 90-kDa; RNA Interference; RNA, Small Interfering; TOR Serine-Threonine Kinases	2019

Article

Year

Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.

BMC cancer, 2015, Aug-08, Volume: 15

Topics: Animals; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; Mice; NF-kappa B; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Transcriptional Activation

2015

Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.

Molecular carcinogenesis, 2019, Volume: 58, Issue:7

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chemoprevention; Drugs, Chinese Herbal; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3 beta; HEK293 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Lignans; Lung Neoplasms; Mice; Molecular Docking Simulation; Phosphorylation; Protein Conformation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Ribosomal Protein S6 Kinases, 90-kDa; RNA Interference; RNA, Small Interfering; TOR Serine-Threonine Kinases

2019